ad image

China

1 / 2
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
BIOSECURE Act

Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?

Pharma's Almanac

PAO-11-24-RT-01Oct 28, 2024
BeiGene
Drug Supply

BeiGene Announces Supply Update for ABRAXANE in China

BeiGene

PR-M03-20-NI-037Mar 25, 2020
WuXi Biologics
Drug Development

WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers

WuXi Biologics

PR-M11-19-NI-018Nov 19, 2019
GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China
China

GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China

Nice Insight

PR-M11-19-NI-015Nov 15, 2019
Amgen
Strategic Collaboration

Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China

Amgen

PR-M10-19-NI-048Nov 01, 2019
LabCorp
R&D

Covance Unveils New R&D Center in Shanghai

LabCorp

PR-M09-19-NI-038Sep 16, 2019
Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million
M&A

Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million

Nice Insight

PAO-M09-19-NI-009Sep 05, 2019
Innovent
Licensing Agreement

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

Innovent

PR-M08-19-NI-076Aug 27, 2019
iBio, Inc.
Collaboration

iBio and CC-Pharming Expand Business Collaboration in China

iBio, Inc.

PR-M08-19-NI-087Aug 26, 2019
Hybrid Human/Monkey Embryos Created by Salk Researchers in China
Research

Hybrid Human/Monkey Embryos Created by Salk Researchers in China

Emilie Branch

Pharma's Almanac

PAO-M08-19-NI-027Aug 22, 2019
China Welcomes Indian Competition in Push to Lower Drug Costs
Drug Pricing

China Welcomes Indian Competition in Push to Lower Drug Costs

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-010Aug 07, 2019
China Eases Generic Drug Market Shake-Up
Generics

China Eases Generic Drug Market Shake-Up

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-001Aug 01, 2019
Celltrion, Inc.
Biosimilars

Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China

Celltrion, Inc.

PR-M07-19-NI-058Jul 23, 2019
China to Introduce Regulations on Gene Editing
Gene Editing

China to Introduce Regulations on Gene Editing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M05-19-NI-031May 29, 2019
GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China
Consumer Healthcare

GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China

Pharma's Almanac

PAO-M04-19-NI-016Apr 10, 2019
ResearchandMarkets
Oncology Drugs

China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs

ResearchandMarkets

PR-M01-19-NI-044-3143Jan 16, 2019
Pall Corporation
New Facility

Pall Opens Center of Excellence in Shanghai

Pall Corporation

PR-M12-18-NI-080Dec 27, 2018
I-Mab
Immunotherapy

I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy

I-Mab

PR-M11-18-NI-014Nov 05, 2018
Foreign Investment: Chinese Capital Backs U.S. Biotech
Investment

Foreign Investment: Chinese Capital Backs U.S. Biotech

Emilie Branch

Pharma's Almanac

PAP-Q4-18-NI-008Oct 26, 2018
Aveo Oncology
New Drug Application

AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China

Aveo Oncology

PR-M09-18-NI-029Sep 12, 2018
1 / 2